Risks to donor Of Hematopoietic stem cell

There Are Five Part Of Risks To Donor Of  Hematopoietic Stem Cell 
Risks To Donor : 
The risks of a complication depend on patient characteristics, health care providers and the apheresis procedure, and the colony-stimulating factor used (G-CSF, GM-CSF). G-CSF drugs include filgrastim (Neupogen, Neulasta), and lenograstim (Graslopin).

  1. Drug risks
  2. Access risks
  3. Clinical observations
  4. Severe reactions
  5. Donor registration and recruitment


Posted by

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)